Study Type
Observational
ongoing
Frailty is being increasingly studied as a predictor of adverse outcomes.
Cumulative evidence has associated frailty with an increased risk of adverse health-related outcomes including falls, disability, hospitalizations and mortality.
Measuring frailty may represent a comprehensive tool for risk prediction.
FARGO is a multicentre, prospective cohort study of patients 55 years old or older with confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.
The primary objective of FARGO is to evaluate the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery.
Download FARGO Overview (PDF)Study Design
Multi-centre, prospective and longitudinal, cohort study
NO. of Countries
1
NO. of Sites
3
NO. of Participants
280
Study Period
2022 - 2024
Sponsor
PHRI
Key Team Members within PHRI
Julie MV Nguyen
Co-Principal Investigator Julie My Van Nguyen is an Assistant Professor in the Department of Obstetrics and Gynecology at McMaster University, and an attending physician in the Division of Gynecologic Oncology at the Juravinski Hospital and Cancer Centre, Hamilton Health Sciences.
Maura Marcucci
Scientist
Maura Marcucci
Scientist
Maura Marcucci is a scientist in the Perioperative and Surgery research group at PHRI, and an Assistant Professor, Department of Medicine, and Department of Health Research Methods, Evidence, and Impact, at McMaster University. Leveraging on her background in vascular medicine, thrombosis and hemostasis disorders, and geriatrics, Maura’s current main focus of clinical research is cardiovascular and neurocognitive outcomes in noncardiac surgery. She is currently the project officer of the PeriOperative ISchemic Evaluation (POISE)-3 trial and principal investigator of the POISE-3 sub-study on delirium and cognitive decline.
She obtained her medical training and residency in Internal Medicine in Italy. In 2012-2013 she completed an MSc in Health Research Methodology and a clinical fellowship in Hematology/Medicine at McMaster University. In 2014-2016 she was an Assistant Professor at the University of Milan in Italy, before returning to Hamilton, Canada.
Jessica Vincent
Program Director
Jessica Vincent
Program Director
Jessica Vincent has more than 15 years’ experience in coordinating and managing large, international clinical trials. As Associate Program Manager, she oversees interventional trials, registries, and observational research studies in the areas of perioperative medicine, cardiac surgery, and digital health.
She holds an Honours Bachelor of Science Degree from Queens University, and a Master of Clinical Epidemiology Degree from the University of Newcastle.
Emily Di Sante
Senior Research Coordinator
Emily Di Sante
Senior Research Coordinator
With over 14 years experience in health research coordination, Emily is passionate about building exceptional teams that make a positive impact on global health. She has an Honours Bachelor’s of Arts degree (University of Guelph), Master’s of Political Science degree (McMaster University) and a certificate in Project Management (University of Toronto).
Her research interests include tobacco control, public and patient involvement, long-term care, evaluation and knowledge translation. At PHRI, she supports the perioperative and surgery studies, B-Free, FARGO, FAST, PREVENT and STRATUS.
